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Summary
The licence of the first human papillomavirus vaccine (HPV) 
has important implications for the most appropriate age for a 
mandatory immunization.
In this paper data taken from a recent study show that more than 
10% of the Italian women report having already had a sexual 
intercourse by the age of 15.
There is thus sufficient evidence to recommend administration of 
the HPV vaccine to all girls by the age of 12.
Tab. I. Sexually active women at different ages (cumulative pro-
portion).
Age at first
intercourse
cumulative %
of sexually active
≤ 12 years 0.9
≤ 13 years 1.8
≤ 14 years 4.0
≤ 15 years 10.5
≤ 16 years 19.6
≤ 17 years 33.9
≤ 18 years 52.0
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Introduction
The recent licence of the first human papillomavirus 
vaccine (HPV) by eMea has opened the debate in many 
countries about the most appropriate policy and, in par-
ticular, the age for a mandatory immunization [1].
There are many important issues related to its imple-
mentation on a national scale. Some of the most im-
portant relate to the beginning of sexual activity and 
therefore to the first age of potential exposure to the 
virus. in addition to this aspect, organizational issues, 
the possibility of performing information campaigns 
and immunogenicity of the vaccine at different ages 
should be addressed too. in italy, the HPV vaccination 
could be given with Td or MMr booster doses, which 
are already administered by the national Health Service 
between the ages of 12 and 15 according to the different 
regional guidelines.
in order to support national and regional health policy 
makers in this decision, data from a recent survey on 
sexual behaviour of the italian population [2] were ana-
lysed. in particular those data concerning sexual activity 
and age at first intercourse.
Methods
in 2002 a national survey financed by the national 
Health institute (istituto Superiore di Sanità – iSS) was 
carried out in the provinces of Milan, Parma, Perugia 
and Bari in order to assess HiV knowledge and risk 
behaviour in the italian general population [2].
a self-administered questionnaire was administered 
to 2,000 subjects, representative of the italian popula-
tion. The sampling was performed by quota with equal 
proportions of age groups, genders, provinces, and 
educational level. of these subjects, 1,000 were women 
aged between 18 and 49 years. The questionnaire was 
aimed at collecting reported information about HiV 
knowledge, sources of information about HiV, impact 
of previous health education campaigns and sexual be-
haviour. in this latter part the interviewees were asked if 
they ever had a sexual intercourse and at what age.
The data were analysed using Stat ViewTM Se_ 1.02 
for Macintosh for univariate analysis and SPSS 11.5 for 
multivariate analysis.
Results and discussion
among the 964 women who ever had a sexual intercourse, 
4% reported having First Human intercourse (FHi) by the 
age of 14 and more than 10% by the age of 15 (Tab. i). 
Moreover the analysis by age cohorts (both males and 
females) shows a decreasing trend in the age at FHi with 
a median age of 17 of the youngest cohort (18-29 years 
old) vs. a median age of 18 of the older cohorts.
Data show that if the vaccine were administered to girls 
older than 12, that would result in a reduced effective-
ness of the immunization campaign.
a further element to consider is that the HPV quad-
rivalent vaccine is immunogenic across a wide range 
of ages, but with the strongest immune responses 
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observed in pre-pubertal girls [3]. These findings re-
flect the involution of the thymus at puberty and the 
decreased ability to mount new immune responses 
thereafter, as already observed with other vaccines 
showing antibodies responses getting lower as age 
increases [4].
Though selection, recall and reporting biases might have in-
fluenced the results of the investigation, the adequate sam-
ple size, the confidentiality guaranteed and the fact that FHi 
reporting is quite unlikely to cause recall bias suggest that 
biases should not have affected significantly the results.
in the light of our data on sexual behaviour [2, 5], the recent 
aCiP recommendations [6] and the scientific evidence, we 
conclude that the ideal age for a mandatory immunization 
is from 9 to 11 and anyway before the age of 12, in order to 
avoid a decrease in effectiveness of the vaccination.
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